Dear Valued Customer,

Catalent Pharma Solutions, the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics, cell and gene therapy and consumer health products, has agreed to acquire RHEINCELL Therapeutics. This strategic decision will allow RHEINCELL to continue to its growth plans and support the cell and gene therapy industry with leading technology and services.

Catalent shares our patient-first philosophy and commitment to providing development partners with the most flexible and high-quality services that allow for accelerated timelines to clinic and ultimately commercial supply. With the addition of RHEINCELL’s expertise in iPSC GMP banks to Catalent’s cell therapy custom development and manufacturing offering, we will be in an even better position to serve you and the broader industry today and into the future across the entire iPSC value chain.

Furthermore, Catalent’s global capabilities and extensive experience in GMP manufacturing, fill/finish, analytics, and clinical supply services will facilitate RHEINCELL in the advancement of our quality systems, processes, and infrastructure. Catalent’s Cell and Gene Therapy Gosselies campus is conveniently located 2.5 hours away from RHEINCELL’s headquarters and production site.

As a RHEINCELL customer, you have been an integral partner in our success. It is your imagination, innovation, and discoveries that have led the advanced biotherapeutics field to the success they are currently experiencing, and we greatly value the life-saving medicines that you will provide to patients in their most critical time of need. This continued partnership is precisely why we will work with you and our new colleagues at Catalent to ensure a smooth transition with no disruption to your programs.

We know how important your products are to you, your investors, and your patients. We, at RHEINCELL and now Catalent, share that feeling, and we are dedicated to continuing to be the partner you need and the partner you want by your side throughout your journey.

We thank you again for being a valued customer and we look forward to providing additional information about this exciting opportunity in the coming months. If you have any questions or concerns in the meantime, please feel free to reach out to me or a member of our team.

Best Regards,


Thomas Marx
Head of Business Development and Commercial Operations